The for-profit nursing home sector, catering to a large segment of the nation's nearly 14,900 facilities, is prioritizing profit over patient care, resulting in widespread neglect and mistreatment of residents. Investigations by The Conversation reveal a concerning landscape where cost-cutting measures and financial maneuvers, including complex networks of related corporations, significantly compromise the quality of care provided to residents. Penalties and fines, often viewed as a cost of doing business, fail to deter the ongoing neglect as federal regulations remain inadequately enforced, allowing owners to profit through financial schemes at the expense of resident well-being. The model is particularly prevalent among midsize chains, which strike a balance between avoiding public scrutiny and maximizing profit by operating in a regulatory environment that struggles to hold them accountable. The pandemic underscored these issues, highlighting how for-profit homes, especially those with lower staffing levels and a history of health violations, were ill-prepared to manage the crisis, leading to further suffering and loss among the nation's most vulnerable populations.

For-profit nursing homes are cutting corners on safety and draining resources with financial shenanigans − especially at midsize chains that dodge public scrutiny The Conversation

In "Rethink What You ‘Know’ About High-Achieving Women," authors Ely, Stone, and Ammerman debunk common misconceptions surrounding the career trajectories of Harvard Business School's female alumni. Their extensive survey on the occasion of the 50th anniversary of women's admission to the program challenges prevalent beliefs, revealing that career aspirations and expectations of both genders are quite similar. They dispel the myth that a significant number of female graduates choose to "opt out" of their careers for family care, showing this does not account for the gender gap in senior management. The findings advocate for companies to reevaluate hiring biases and foster an equitable environment for all employees, emphasizing the need to address the outdated stereotype that women are more likely to abandon their careers after becoming parents.

Rethink What You “Know” About High-Achieving Women Harvard Business Review

The Biden-Harris Administration convened a White House roundtable to address the high costs of prescription drugs and the role of middlemen in the pharmaceutical industry. Senior officials, including National Economic Advisor Lael Brainard and Secretary of Health and Human Services Xavier Becerra, engaged with state leaders, the private sector, and community pharmacies to explore solutions for lowering healthcare costs and increasing transparency in drug pricing. The discussion emphasized the need for reforms to enhance transparency, foster competition, support independent pharmacies, and ultimately reduce drug costs for Americans. Key highlights included Kentucky's initiative saving $300 million in pharmaceutical expenditures, the personal and community benefits of PBM transparency, and the detrimental impact of market distortions and lack of transparency on independent pharmacies and drug pricing. The Administration highlighted ongoing efforts under the Inflation Reduction Act to negotiate drug prices for Medicare, cap insulin costs, and reduce health insurance premiums, signaling a commitment to further action in these areas.

Readout of White House Roundtable on Lowering Healthcare Costs and Bringing Transparency to Prescription Drug Middlemen | The White House The White House

Elon Musk's Neuralink has debuted its brain-computer interface in a live demonstration, showcasing a paralyzed man, Noland Arbaugh, who, thanks to the Neuralink implant, is now able to control a computer cursor with his thoughts. This significant development opens new possibilities for individuals with severe physical disabilities, offering them a greater level of independence and interaction with technology. Unlike previous brain-computer interfaces, Neuralink's device operates wirelessly and can be used outside the confines of laboratory settings, promoting a more accessible and versatile application. This advancement not only represents a leap forward in assistive technology but also hints at Neuralink's broader ambitions to augment human capabilities in the face of advancing artificial intelligence.

Elon Musk’s Neuralink Shows First Patient Using Its Brain Implant The Wall Street Journal

The for-profit nursing home sector, catering to a large segment of the nation's nearly 14,900 facilities, is prioritizing profit over patient care, resulting in widespread neglect and mistreatment of residents. Investigations by The Conversation reveal a concerning landscape where cost-cutting measures and financial maneuvers, including complex networks of related corporations, significantly compromise the quality of care provided to residents. Penalties and fines, often viewed as a cost of doing business, fail to deter the ongoing neglect as federal regulations remain inadequately enforced, allowing owners to profit through financial schemes at the expense of resident well-being. The model is particularly prevalent among midsize chains, which strike a balance between avoiding public scrutiny and maximizing profit by operating in a regulatory environment that struggles to hold them accountable. The pandemic underscored these issues, highlighting how for-profit homes, especially those with lower staffing levels and a history of health violations, were ill-prepared to manage the crisis, leading to further suffering and loss among the nation's most vulnerable populations.

For-profit nursing homes are cutting corners on safety and draining resources with financial shenanigans − especially at midsize chains that dodge public scrutiny The Conversation

In "Rethink What You ‘Know’ About High-Achieving Women," authors Ely, Stone, and Ammerman debunk common misconceptions surrounding the career trajectories of Harvard Business School's female alumni. Their extensive survey on the occasion of the 50th anniversary of women's admission to the program challenges prevalent beliefs, revealing that career aspirations and expectations of both genders are quite similar. They dispel the myth that a significant number of female graduates choose to "opt out" of their careers for family care, showing this does not account for the gender gap in senior management. The findings advocate for companies to reevaluate hiring biases and foster an equitable environment for all employees, emphasizing the need to address the outdated stereotype that women are more likely to abandon their careers after becoming parents.

Rethink What You “Know” About High-Achieving Women Harvard Business Review

The Biden-Harris Administration convened a White House roundtable to address the high costs of prescription drugs and the role of middlemen in the pharmaceutical industry. Senior officials, including National Economic Advisor Lael Brainard and Secretary of Health and Human Services Xavier Becerra, engaged with state leaders, the private sector, and community pharmacies to explore solutions for lowering healthcare costs and increasing transparency in drug pricing. The discussion emphasized the need for reforms to enhance transparency, foster competition, support independent pharmacies, and ultimately reduce drug costs for Americans. Key highlights included Kentucky's initiative saving $300 million in pharmaceutical expenditures, the personal and community benefits of PBM transparency, and the detrimental impact of market distortions and lack of transparency on independent pharmacies and drug pricing. The Administration highlighted ongoing efforts under the Inflation Reduction Act to negotiate drug prices for Medicare, cap insulin costs, and reduce health insurance premiums, signaling a commitment to further action in these areas.

Readout of White House Roundtable on Lowering Healthcare Costs and Bringing Transparency to Prescription Drug Middlemen | The White House The White House

Elon Musk's Neuralink has debuted its brain-computer interface in a live demonstration, showcasing a paralyzed man, Noland Arbaugh, who, thanks to the Neuralink implant, is now able to control a computer cursor with his thoughts. This significant development opens new possibilities for individuals with severe physical disabilities, offering them a greater level of independence and interaction with technology. Unlike previous brain-computer interfaces, Neuralink's device operates wirelessly and can be used outside the confines of laboratory settings, promoting a more accessible and versatile application. This advancement not only represents a leap forward in assistive technology but also hints at Neuralink's broader ambitions to augment human capabilities in the face of advancing artificial intelligence.

Elon Musk’s Neuralink Shows First Patient Using Its Brain Implant The Wall Street Journal